Choose a Section
May 13, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
‘Overwhelming’ support for hormone therapy in cervical cancer, but barriers limit use
Most gynecologic oncologists and radiation oncologists would consider prescribing hormone therapy for patients with cervical cancer who receive chemoradiotherapy, but barriers inhibit adoption for many.A survey of more than 150 clinicians showed approximately 25% have concerns about long-term management of treatment. Additionally, many remain unaware of guideline-recommended care, and some still
TL;DRAI
Survey of 178 oncologists finds 99.3% of gynecologic oncologists would prescribe hormone therapy post-chemoradiotherapy for cervical cancer, yet only ~1 in 3 patients currently receives it. Radiation oncologists' limited HRT training (42.5% cite long-term management as barrier) and guideline unawareness drive a survivorship care gap that oncology teams need to close.
1,492 words~7 min read
